top of page

Browse by category

Search

SELECT trial: Semaglutide reduces the risk of MACE by 20% in adults with overweight or obesity

SELECT trial: Semaglutide reduces the risk of MACE by 20% in adults with overweight or obesity

Results from the SELECT cardiovascular outcomes trial has revealed that semaglutide 2.4mg demonstrated a statistically significant and...

LSG with Nissen Fundoplication has higher prevalence of comorbidities and a longer hospital length of stay

3 hours ago

Journal watch 2/10/2024

1 day ago

EndoZip Endoscopic Suturing System results in an average TBWL of 13.21% at 12 months

2 days ago

bottom of page